The viral diagnostic test kits global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Viral Diagnostic Test Kits Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $15.07 billion in 2023 to $16.26 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing healthcare expenditure, increasing global travel, a rise in chronic viral infections, a rise in demand for home testing kits, and growth in personalized medicine.
The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $22.23 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing ebola virus infections, increasing hemorrhagic fever, rising prevalence of viral infections, increasing prevalence of respiratory syncytial virus, and increasing prevalence of hepatitis. Major trends in the forecast period include technological advancements, point-of-care testing, AI and data analytics, integration with digital health records, and next-generation sequencing.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report
Scope Of Viral Diagnostic Test Kits Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Viral Diagnostic Test Kits Market Overview
Market Drivers –
The rising prevalence of viral infections is expected to propel the growth of the viral diagnostic test kits market going forward. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can lead to a broad spectrum of symptoms ranging from mild to severe across different body parts. The incidence of viral infections is increasing due to global travel, urbanization, climate change influencing vector-borne diseases, and evolving viral strains that can cause new outbreaks or expand into new geographical regions. Viral diagnostic test kits are instrumental in identifying and confirming the presence of specific viral infections in patients by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, in 2022, there were 2,126 new cases of acute hepatitis B reported, alongside 16,729 newly reported cases of chronic hepatitis B. Further, in the period, 14 jurisdictions in the US reported rates of acute hepatitis B higher than the national average in the United States. Therefore, the rising prevalence of viral infections is driving the growth of the viral diagnostic test kits market.
Market Trends –
Major companies operating in the viral diagnostic test kits market are developing innovative products, such as rapid diagnostics tools, to sustain their position in the market. Rapid diagnostics tools refer to diagnostic tools and tests designed to quickly and accurately detect various medical conditions, including infectious diseases, metabolic disorders, and other health conditions. For instance, in July 2021, Abbott Laboratories, a US-based medical device company, launched the Panbio COVID-19 Antigen Self-Test Kit to detect the SARS-CoV-2 virus in adults and children in India. This self-test kit offers a quick and convenient way to detect COVID-19, delivering reliable results in just 15 minutes. The test is easy to use, requiring only a nasal swab, and includes clear instructions to ensure accurate self-administration. It aims to support public health efforts in controlling the spread of COVID-19, empowering individuals with a tool for timely diagnosis and immediate action.
The viral diagnostic test kits market covered in this report is segmented –
1) By Test: Traditional Tests, Rapid Test
2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types
3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users
Get an inside scoop of the viral diagnostic test kits market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16821&type=smp
Regional Insights –
North America was the largest region in the viral diagnostic test kits market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A. , Trinity Biotech plc, Biodesix Inc.
Table of Contents
1. Executive Summary
2. Viral Diagnostic Test Kits Market Report Structure
3. Viral Diagnostic Test Kits Market Trends And Strategies
4. Viral Diagnostic Test Kits Market – Macro Economic Scenario
5. Viral Diagnostic Test Kits Market Size And Growth
…..
27. Viral Diagnostic Test Kits Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
